ArticleACS pharmacology & translational science2020
Modulation of Lymphocyte Potassium Channel K
Open access · bronzeAbstract read
In one paragraph
Article in ACS pharmacology & translational science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 24 citations in OpenAlex.
- Selective α-Amylase Inhibition by Plant Defensins: Structural Determinants, Engineering Strategies, and Translational Prospects.Probiotics and antimicrobial proteins · 2026Review
- Sketching microprotein portraits.Protein science : a publication of the Protein Society · 2026Review
- Antifungal Plant Defensins as an Alternative Tool to Combat Candidiasis.Plants (Basel, Switzerland) · 2024Review
- Characterization of nanodisc-forming peptides for membrane protein studies.Journal of colloid and interface science · 2024Article
- Immunomodulatory Effects of the Pea Defensin Psd1 in the Caco-2/Immune Cells Co-Culture uponInternational journal of molecular sciences · 2023Article
- A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.PloS one · 2023Article
- Imaging Memory T-Cells Stratifies Response to Adjuvant Metformin Combined with αPD-1 Therapy.International journal of molecular sciences · 2022Article
- Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer.Biomedicines · 2022Article
- Antifungal Activity, Structural Stability, and Immunomodulatory Effects on Human Immune Cells of Defensin from the LentilMembranes · 2022Article
- Detergent-Free Isolation of Membrane Proteins and Strategies to Study Them in a Near-Native Membrane Environment.Biomolecules · 2022Review
- Defensin-lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics.Biochemical Society transactions · 2022Review
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 8 institutions in 3 countries.
Seow Theng OngLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Saumya BajajLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Mark R TannerDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, United States.
Shih Chieh ChangLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Bankala KrishnarjunaMedicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Xuan Rui NgLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Rodrigo A V MoralesMedicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Ming Wei ChenLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Dahai LuoLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Dharmeshkumar PatelSchool of Physics, University of Sydney, Sydney, New South Wales 2006, Australia.
Sabina YasminSchool of Physics, University of Sydney, Sydney, New South Wales 2006, Australia.
Jeremy Jun Heng NgLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Zhong ZhuangLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Hai M NguyenDepartment of Pharmacology, University of California, Davis, California 95616, United States.
Abbas El SahiliSchool of Biological Sciences, Nanyang Institute of Structural Biology, Experimental Medicine building, Singapore 636921.
Julien LescarSchool of Biological Sciences, Nanyang Institute of Structural Biology, Experimental Medicine building, Singapore 636921.
Rahul PatilCentre for Drug Candidate Optimisation, Monash University, Parkville, Victoria 3052, Australia.
Susan A CharmanCentre for Drug Candidate Optimisation, Monash University, Parkville, Victoria 3052, Australia.
Edward G RobinsSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A Star), Singapore 138667.
Julian L GoggiSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A Star), Singapore 138667.
Peng Wen TanSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A Star), Singapore 138667.
Pragalath SadasivamSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A Star), Singapore 138667.
Boominathan RamasamySingapore Bioimaging Consortium, Agency for Science, Technology and Research (A Star), Singapore 138667.
Siddana V HartimathSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A Star), Singapore 138667.
Vikas DhawanPeptides International, Inc., Louisville, Kentucky 40269, United States.
Janna BednenkoTetraGenetics Inc, Arlington, Massachusetts 02474, United States.
Paul ColussiTetraGenetics Inc, Arlington, Massachusetts 02474, United States.
Heike WulffDepartment of Pharmacology, University of California, Davis, California 95616, United States.
Michael W PenningtonPeptides International, Inc., Louisville, Kentucky 40269, United States.
Serdar KuyucakSchool of Physics, University of Sydney, Sydney, New South Wales 2006, Australia.
Raymond S NortonMedicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Christine BeetonDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, United States.
K George ChandyLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Experimental Medicine Building, 59 Nanyang Drive, Singapore 636921.
Nanyang Technological University · SGAgency for Science, Technology and Research · SGMonash University · AUThe University of Sydney · AUBaylor College of Medicine · USPeptides International (United States) · USTetraGenetics (United States) · USUniversity of California, Davis · US
Funding
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9MUM1HG006348: Cas9 Genome Integrity Supplemental ProposalUM1HG006348 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI Jason D. Heaney, Chih-Wei Logan Hsu · 2016 to 2026
$47.5MConsortium for Broad Based Disease Phenotyping of Knockout MiceU54HG006348 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L., PAYLOR, RICHARD E · 2011 to 2015
$17.0MKOMP Phase II Mouse PhenotypingU54HG006364 · NHGRI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2011 to 2015
$16.3MMolecular Physiology of the Cardiovascular SystemT32HL007676 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI HAMILTON, SUSAN L · 1989 to 2020
$7.9MMicroglial K+ Channels in Ischemic StrokeR01NS100294 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WULFF, HEIKE · 2017 to 2020
$1.3MNCI NIH HHS P30 CA125123NHGRI NIH HHS U54 HG006348NHGRI NIH HHS U54 HG006364NHGRI NIH HHS UM1 HG006348NHLBI NIH HHS T32 HL007676NINDS NIH HHS R01 NS100294
Abstract
We describe a cysteine-rich, membrane-penetrating, joint-targeting, and remarkably stable peptide, EgK5, that modulates voltage-gated K
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.